EP2224941

USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    2.6.2009
  • :
    29.2.2012
  • :
    09753693.2
  • :
    USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES

2.6.2009
29.2.2012
  • :
    Xigen S.A.
  • :
    Route de la Corniche 4, 1066, Epalinges, CH
  • :
    BONNY, Christophe
  • :
    Lausanne, CH
  • :
    PCT/EP2008/004340
  • :
    30.5.2008
  • :
    WO
  • :
    WO2009144038
  • :
    2.6.2009
  • :
    A61K 38/01, A61K 38/03, A61K 38/04, A61P 29/00, A61P 1/04